FDA.reportPublic FDA data

OraVerse 0.235 MG/ML per 1.7 ML Cartridge

RxCUI
1361021
RxNorm name
OraVerse 0.235 MG/ML per 1.7 ML Cartridge
Display name
OraVerse 0.235 MG/ML per 1.7 ML Cartridge
Full name
OraVerse 0.235 MG/ML per 1.7 ML Cartridge
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OraversePHENTOLAMINE MESYLATESeptodont, Inc.4025cf98-ea87-4531-b0fc-6283c84f63f32018-12-05Warnings, Adverse reactionsExact identifier
rxcui: 1361021

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4025cf98-ea87-4531-b0fc-6283c84f63f3OraVerse 0.4 MG in 1.7 ML Cartridge [PSN] · 1.7 ML phentolamine mesylate 0.235 MG/ML Cartridge [OraVerse] [SBD] · OraVerse 0.235 MG/ML per 1.7 ML Cartridge [SY] · OraVerse 0.4 MG per 1.7 ML Cartridge [SY]44These highlights do not include all the information needed to use OraVerse™ safely and effectively. See full prescribing information for OraVerse. OraVerse (phentolamine mesylate) Injection Initial U.S. Approval: 195220181205
38be9414-87c4-4a8a-9f17-99be0d0a33faOraVerse 0.4 MG in 1.7 ML Cartridge [PSN] · 1.7 ML phentolamine mesylate 0.235 MG/ML Cartridge [OraVerse] [SBD] · OraVerse 0.235 MG/ML per 1.7 ML Cartridge [SY] · OraVerse 0.4 MG per 1.7 ML Cartridge [SY]4120080523